Correlation Between Enfusion and Issuer Direct

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enfusion and Issuer Direct at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Issuer Direct into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Issuer Direct Corp, you can compare the effects of market volatilities on Enfusion and Issuer Direct and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Issuer Direct. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Issuer Direct.

Diversification Opportunities for Enfusion and Issuer Direct

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Enfusion and Issuer is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Issuer Direct Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Issuer Direct Corp and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Issuer Direct. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Issuer Direct Corp has no effect on the direction of Enfusion i.e., Enfusion and Issuer Direct go up and down completely randomly.

Pair Corralation between Enfusion and Issuer Direct

Given the investment horizon of 90 days Enfusion is expected to generate 0.84 times more return on investment than Issuer Direct. However, Enfusion is 1.19 times less risky than Issuer Direct. It trades about 0.01 of its potential returns per unit of risk. Issuer Direct Corp is currently generating about -0.05 per unit of risk. If you would invest  1,172  in Enfusion on October 20, 2024 and sell it today you would lose (65.00) from holding Enfusion or give up 5.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Enfusion  vs.  Issuer Direct Corp

 Performance 
       Timeline  
Enfusion 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.
Issuer Direct Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Issuer Direct Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Enfusion and Issuer Direct Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enfusion and Issuer Direct

The main advantage of trading using opposite Enfusion and Issuer Direct positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Issuer Direct can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Issuer Direct will offset losses from the drop in Issuer Direct's long position.
The idea behind Enfusion and Issuer Direct Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins